Federated Hermes Inc. Sells 65,881 Shares of Masimo Co. (NASDAQ:MASI)

Federated Hermes Inc. decreased its position in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 55.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 52,734 shares of the medical equipment provider's stock after selling 65,881 shares during the quarter. Federated Hermes Inc. owned 0.10% of Masimo worth $8,717,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of MASI. Jones Financial Companies Lllp bought a new position in Masimo in the fourth quarter valued at approximately $27,000. UMB Bank n.a. lifted its position in shares of Masimo by 180.9% during the 4th quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider's stock worth $32,000 after buying an additional 123 shares during the last quarter. Trust Co. of Vermont bought a new stake in shares of Masimo during the 4th quarter worth $33,000. Blue Trust Inc. boosted its stake in Masimo by 56.3% in the fourth quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider's stock valued at $33,000 after buying an additional 71 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in Masimo by 40.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider's stock valued at $37,000 after acquiring an additional 64 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Trading Down 1.0 %

MASI stock traded down $1.48 during trading on Tuesday, hitting $152.13. The company had a trading volume of 162,984 shares, compared to its average volume of 654,337. The stock has a market cap of $8.22 billion, a PE ratio of 104.92 and a beta of 1.28. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. Masimo Co. has a one year low of $101.61 and a one year high of $194.88. The business has a 50-day moving average of $170.11 and a 200-day moving average of $164.63.

Remove Ads

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The medical equipment provider reported $1.80 EPS for the quarter, topping the consensus estimate of $1.42 by $0.38. The company had revenue of $600.70 million during the quarter, compared to the consensus estimate of $593.35 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. Research analysts predict that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on MASI shares. Wells Fargo & Company raised their price target on shares of Masimo from $193.00 to $205.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. Raymond James boosted their target price on shares of Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a research note on Friday, December 27th. Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a research note on Thursday, April 10th. Finally, Piper Sandler boosted their price objective on Masimo from $210.00 to $215.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, Masimo has an average rating of "Moderate Buy" and a consensus target price of $194.80.

Insider Buying and Selling

In related news, COO Bilal Muhsin sold 30,000 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $167.49, for a total value of $5,024,700.00. Following the transaction, the chief operating officer now directly owns 24,172 shares of the company's stock, valued at approximately $4,048,568.28. The trade was a 55.38 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Craig B. Reynolds sold 2,053 shares of the firm's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $166.13, for a total transaction of $341,064.89. Following the sale, the director now owns 16,581 shares of the company's stock, valued at $2,754,601.53. This trade represents a 11.02 % decrease in their position. The disclosure for this sale can be found here. 9.70% of the stock is currently owned by company insiders.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.